Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep654 | Endocrine-related Cancer | ECE2023

Weight loss in diabetics of 2 unbalanced revealing neoplasia

Ouhessaine Sofia , Essabah Haraj Nassim , El Aziz Siham , Chadli Asma

Introduction: The incidence of cancer has increased in case of diabetes, as well as the metabolic abnormalities observed during diabetes could have a critical role on carcinogen, nevertheless one should not deny the implication of common factors to diabetes and cancer (obesity, smoking, advanced age, etc).Study objectives: Describe the biological and morphological screening methods for neoplasia in the event of weight loss concomitant with chronic glycem...

ea0065p376 | Reproductive Endocrinology and Biology | SFEBES2019

Too much of a good thing – two cases of severe dilutional peripartum hyponatraemia with lessons to learn

Page Tristan , Bosworth Kate , Peers Sofia , Sukumaran Suganya , Baskar Varadarajan

Peripartum hyponatraemia is an under-recognised complication of labour and poses a risk to both mother and baby. It is typically caused by water intoxication for physiological reasons and population health trends around water intake. We have recent experience of managing 2 patients with severe symptomatic hyponatraemia. Both patients had increased their oral intake of fluid during labour as well as receiving intravenous fluids. Dilutional hyponatraemia was found to be the unde...

ea0067gp22 | Poster Presentations | EYES2019

Atypical manifestation of pheochromocytoma

Gheorghiu Monica-Livia , Burciulescu Sofia-Maria Lider , Ionescu Luminita Nicoleta

Background: Tako-tsubo cardiomyopathy (TTC) is a non-ischemic condition manifested with a temporary weakening of the myocardium after an acute stress. The association between pheochromocytoma (PHEO) and TTC is rare and is attributed to catecholamine excess. We present a case of a young women with an atypical manifestation of PHEO.Clinical case: Patient, F, aged 37, known with multinodular goiter with hypothyroidism for several years, having paroxysmal hy...

ea0063p915 | Diabetes, Obesity and Metabolism 3 | ECE2019

Profile of patients using continuous subcutaneous insulin infusion in portugal

Osorio Ana Sofia , do Vale Sonia , Cruz Diogo

Introduction: Continuous subcutaneous insulin infusion (CSII) represents a treatment option that helps patients with type 1 diabetes (PwT1D) to achieve better glycemic control, reduces hypoglycemia and improves quality of life. In Portugal, the National Health System (SNS) affords CSII treatment to PwT1D, according to certain criteria. Over the years, the number of patients treated with CSII devices supported by SNS has grown exponentially. We analyzed these patient’s pro...

ea0049ep996 | Pituitary - Clinical | ECE2017

Sheehan syndrome presenting 21 years later as severe heart failure

Ferreira Ana Goncalves , Alegria Sofia , Cordeiro Maria Carlos , Portugal Jorge

Introduction: Sheehan syndrome (SS) is caused by postpartum necrosis of the pituitary gland, associated with significant haemorrhage during or after delivery. It is rare in developed countries, but still frequent in underdeveloped ones. We present a rare presentation of this syndrome.Clinical case: A 48 years old black woman presented at the emergency department for long term fatigue and dyspnea that worsened a few days before. Her physical examination r...

ea0044p205 | Reproduction | SFEBES2016

An audit of success rates of the induction of spermatogenesis clinic at University College London Hospitals

Dimakopoulou Anastasia , Ojewuyi Taofeek , Llahana Sofia , Baldeweg Stephanie , Conway Gerard

Introduction and aim: In the UK, 15% of couples are affected by infertility which is due to primary or secondary male factors in 30%. Induction of spermatogenesis with gonadotrophins is a long established endocrine treatment for gonadotrophin deficiency. However, there are concerns that some patient groups have very low success rates. The aim of our audit was to define success of spermatogenesis and fertility rates amongst these men.Methods: We retrospec...

ea0041ep426 | Diabetes (to include epidemiology, pathophysiology) | ECE2016

Diagnostic and therapeutic stratagies in maturity onset diabetes of the young

Oliveira Sofia , Neves Celestino , Esteves Cesar , Pignatelli Duarte , Carvalho Davide

Background: Maturity onset diabetes of the young (MODY) has an estimated prevalence of 1–5% in the diabetic population, but misdiagnosis as type 1 or type 2 diabetes is common. It comprises a heterogeneous group of monogenic diseases characterized by primary dysfunction of β cell, young onset, autosomal dominant inheritance, without autoimmunity and without ketosis. Early diagnosis remains a challenge with important future implications, since it allows treatment opti...

ea0039ep83 | Miscellaneous/other | BSPED2015

Determination of pancreatic hormones in children with different forms of hyperinsulinaemic hypoglycaemia

Guemes Maria , Morgan Kate , Gilbert Clare , Rahman Sofia , Hussain Khalid

Introduction: In congenital hyperinsulinism (CHI) hypoglycaemia results from a dysregulation of insulin secretion. We hypothesised that other pancreatic hormones may also be dysregulated in this condition.Objectives: To proof the applicability of Luminex Multiplex method to measure pancreatic hormones (insulin, C-peptide, glucagon, amylin and PP) in the paediatric age. To elucidate the fasting response of these hormones in children with different forms o...

ea0036oc4.6 | Oral Communications 4 | BSPED2014

Evaluating dipeptidyl peptidase-4 expression in patients with diffuse and focal congenital hyperinsulinism.

Rahman Sofia A , Sherif Maha M A , Tahir Sophia , Hussain Khalid

Background: Congenital hyperinsulinism (CHI) is the commonest cause of persistent hypoglycaemia and is due to the unregulated secretion of insulin from the pancreatic beta-cells. The role of gut hormones and dipeptidyl peptidase-4 (DPP-4) is currently unknown in patients with CHI.Aims: To evaluate the expression pattern of DPP-4 in focal and diffuse CHI.Method: Using intra-operative formalin-fixed paraffin embedded (FFPE) pancreati...

ea0022p170 | Cardiovascular endocrinology and lipid metabolism | ECE2010

Formation of neutralizing anti human growth hormone (hGH) antibodies does not explain the lack of IGF1 increase after recombinant hGH treatment in mice

Mustafina Svetlana , Rymar Oksana , Simonova Galina , Malyutina Sofia , Nikitin Yuri

We previously have reported that short-term treatment of mice with recombinant hGH leads to significant increases in bodyweight (BW), lean body mass (LBM) and liver weight, but – unlike in humans – does not robustly increase circulating levels of IGF1. We now tested the hypothesis that formation of neutralizing antibodies in mice treated with rhGH could explain the lack of IGF1 response. Therefore, we intentionally induced antibody formation against hGH in female FVB...